The Current Ratio as of December 2025 (TTM) for Isofol Medical AB (publ) (ISOFOL.ST) is 6.80

According to Isofol Medical AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 6.80. This represents a change of 37.85% compared to the average of 4.94 of the last 4 quarters.

Isofol Medical AB (publ) (ISOFOL.ST) Historical Current Ratio (quarterly & annually)

How has ISOFOL.ST Current Ratio performed in the past?

The mean historical Current Ratio of Isofol Medical AB (publ) over the last ten years is 6.11. The current 6.80 Current Ratio has changed 11.03% with respect to the historical average. Over the past ten years (40 quarters), ISOFOL.ST's Current Ratio was at its highest in in the September 2017 quarter at 42.87. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Isofol Medical AB (publ) (ISOFOL.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Isofol Medical AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Isofol Medical AB (publ) (ISOFOL.ST) Average Current Ratio

How has ISOFOL.ST Current Ratio performed in the past?

The current Current Ratio of Isofol Medical AB (publ) (ISOFOL.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Isofol Medical AB (publ) (ISOFOL.ST) Current Ratio vs. Peers

How is ISOFOL.ST’s Current Ratio compared to its peers?

Isofol Medical AB (publ)’s Current Ratio is less than Annexin Pharmaceuticals AB (publ) (9.32), greater than IRLAB Therapeutics AB (publ) (1.30), greater than Lipum AB (publ) (0.62), greater than Initiator Pharma A/S (4.15), less than Karolinska Development AB (publ) (7.99), greater than Enorama Pharma AB (publ) (0.71), greater than Bio-Works Technologies AB (publ) (2.26), greater than Clinical Laserthermia Systems AB (publ) (3.64), greater than Alzinova AB (publ) (0.20), greater than Xbrane Biopharma AB (publ) (3.47),

Build a custom stock screener for Isofol Medical AB (publ) (ISOFOL.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Isofol Medical AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Isofol Medical AB (publ) (ISOFOL.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Isofol Medical AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.